Monthly archive | PharmaTutor

7 January 2026

Walk In Drive for MPharm, BPharm, MSc in Production and Packing at Otsuka Pharma

Seeking young, skilled professionals with experience in parenteral/injectable formulations for our manufacturing facility in Ahmedabad, Gujarat

7 January 2026

Aurigene Invites Applications for Research Associate in Life Sciences & Biotechnology

Experience in preparation of ultra competent cells and transformation with chemical and electroporation methods.

7 January 2026

Ipca Laboratories Conducts Walk-In for Freshers in Quality Control

Upon successful completion of the training, selected candidates will be absorbed at various Ipca Laboratories locations as per compatibility and skills

7 January 2026

Senores Pharmaceuticals Hiring: F&D, ADL, QC, Regulatory Affairs

Solid Oral Formulation Development, QbD, Scale-Up, Pilot Batches & Tech Transfer. Literature Review & Excipient Compatibility.

7 January 2026

Europe Greenlights Easier-to-Use Shingrix Vaccine Format for Shingles Prevention

GSK has announced a significant regulatory milestone in adult immunisation with the European Commission’s approval of a new prefilled syringe presentation for its widely used shingles vaccine, Shingrix. This updated format is designed to simplify the administration process for healthcare professionals by removing the need to mix components before injection — a step required in the current two-vial version. The approval paves the way for rollout across EU countries throughout 2026.

7 January 2026

Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis

Researchers have identified a promising new treatment strategy for liver fibrosis, a chronic condition that can lead to cirrhosis and liver cancer, by combining two well-known drugs. Preliminary findings suggest that using silybin together with carvedilol produces a powerful synergistic effect significantly stronger than either drug alone, against the cellular processes that drive scar tissue formation in the liver.

7 January 2026

Infant gut molecules offer clues to type 1 Diabetes risk

In a groundbreaking study, scientists have uncovered a new class of gut-derived molecules in infancy that could reshape how researchers understand the development of type 1 diabetes. The international research team, led by experts at the University of Turku and Örebro University, investigated stool samples from more than 300 children between the ages of 3 and 36 months, all of whom had a genetic predisposition for type 1 diabetes.